These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18510544)

  • 21. Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis.
    Gan L; O'Hanlon TP; Gordon AS; Rider LG; Miller FW; Burbelo PD
    BMC Musculoskelet Disord; 2014 Mar; 15():67. PubMed ID: 24602337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine lupus strains differentially model unique facets of human lupus serology.
    Li L; Nukala S; Du Y; Han J; Liu K; Hutcheson J; Pathak S; Li Q; Mohan C
    Clin Exp Immunol; 2012 May; 168(2):178-85. PubMed ID: 22471278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls.
    Lourdudoss C; Ajeganova S; Frostegård J
    Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE.
    Grönwall C; Akhter E; Oh C; Burlingame RW; Petri M; Silverman GJ
    Clin Immunol; 2012 Mar; 142(3):390-8. PubMed ID: 22297166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
    Wisnieski JJ; Jones SM
    J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revisiting autoantibody profiles in systemic lupus erythematosus.
    Olhoffer IH; Peng SL; Craft J
    J Rheumatol; 1997 Feb; 24(2):297-302. PubMed ID: 9034986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An antibody profile of systemic lupus erythematosus detected by antigen microarray.
    Fattal I; Shental N; Mevorach D; Anaya JM; Livneh A; Langevitz P; Zandman-Goddard G; Pauzner R; Lerner M; Blank M; Hincapie ME; Gafter U; Naparstek Y; Shoenfeld Y; Domany E; Cohen IR
    Immunology; 2010 Jul; 130(3):337-43. PubMed ID: 20201986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus.
    Lewis MJ; McAndrew MB; Wheeler C; Workman N; Agashe P; Koopmann J; Uddin E; Morris DL; Zou L; Stark R; Anson J; Cope AP; Vyse TJ
    J Autoimmun; 2018 Jul; 91():1-12. PubMed ID: 29576246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibody profiling to follow evolution of lupus syndromes.
    Olsen NJ; Li QZ; Quan J; Wang L; Mutwally A; Karp DR
    Arthritis Res Ther; 2012 Jul; 14(4):R174. PubMed ID: 22838636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
    Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
    J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
    Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z
    Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural autoantibody repertoire in newborns and adults: a current overview.
    Madi A; Bransburg-Zabary S; Kenett DY; Ben-Jacob E; Cohen IR
    Adv Exp Med Biol; 2012; 750():198-212. PubMed ID: 22903676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.
    Jenks SA; Palmer EM; Marin EY; Hartson L; Chida AS; Richardson C; Sanz I
    Arthritis Rheum; 2013 Dec; 65(12):3165-75. PubMed ID: 23983101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heavy and light chain utilization in autoantibodies of elderly patients with systemic lupus erythematosus.
    Ward MM; Pisetsky DS
    Clin Immunol Immunopathol; 1990 Nov; 57(2):280-96. PubMed ID: 2208808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Singh VV; Rai R; Rai M; Rai G
    J Clin Immunol; 2014 May; 34(4):491-503. PubMed ID: 24659206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies to histone, DNA and nucleosome antigens in canine systemic lupus erythematosus.
    Monestier M; Novick KE; Karam ET; Chabanne L; Monier JC; Rigal D
    Clin Exp Immunol; 1995 Jan; 99(1):37-41. PubMed ID: 7529150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis.
    Cambridge G; Wallace H; Bernstein RM; Leaker B
    Br J Rheumatol; 1994 Feb; 33(2):109-14. PubMed ID: 8162472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin class and subclass profile of the Ro/SS-A autoantibody response.
    Lieu TS; Reimer CB; Sontheimer RD
    J Invest Dermatol; 1988 Feb; 90(2):158-64. PubMed ID: 3123558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.